Wang Ya-Qiong, Qi Lian-Wen, Aa Jiye, Wang Guang-Ji, Gao Wen, Cheng Shu-Jie, Wang Zhen-Zhong, Xiao Wei, Li Ping
State Key Laboratory of Natural Medicines (China Pharmaceutical University), Nanjing, China.
Biomed Chromatogr. 2012 Oct;26(10):1286-96. doi: 10.1002/bmc.2695. Epub 2012 Feb 2.
Herbal formulations are complex natural mixtures. Researchers usually tend to focus more on analysis of nonvolatile components but pay less attention to volatile compounds. In this study, an analytical strategy combining two approaches was established for comprehensive analysis of herbal formulations. Guizhi Fuling capsule (GFC), a drug approved by the FDA to enter phase II clinical trial for treatment of primary dysmenorrhea, was taken as a case for analysis. Gas chromatography-mass spectrometry (GC-MS) with automated mass spectral deconvolution and identification system (AMDIS) led to rapid identification of 48 volatile components including four acetophenones, three fatty acid esters, 13 phenylpropanoids and 19 sesquiterpenes. Most of them were found from Guizhi. The volatile oils of Guizhi have been proved to exhibit many pharmacological activities. This is helpful in understanding the pharmacological mechanism of GFC. Furthermore, AMDIS turned out to be efficient and reliable for analysis of complex herbal formulations. Rapid-resolution liquid chromatography (RRLC) coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (ESI-Q-TOF MS/MS) allowed the identification of 70 nonvolatile components including six acetophenones, 12 galloyl glucoses, 31 monoterpene glycosides, three phenols and 12 triterpene acids. Fragmentation behaviors of assigned components, especially triterpene acids, which are hard to identify by low-resolution MS, were first investigated by TOF MS/MS. Characteristic ions and typical loss of assigned triterpene acids were summarized. Combinatorial use of GC-MS-AMDIS and RRLC-ESI-Q-TOF MS/MS could be of great help in global qualitative analysis of GFC, as well as other herbal products.
中药制剂是复杂的天然混合物。研究人员通常更倾向于关注非挥发性成分的分析,而对挥发性化合物的关注较少。在本研究中,建立了一种结合两种方法的分析策略,用于中药制剂的综合分析。以已获美国食品药品监督管理局(FDA)批准进入治疗原发性痛经II期临床试验的药物桂枝茯苓胶囊(GFC)为例进行分析。气相色谱-质谱联用仪(GC-MS)与自动质谱解卷积和鉴定系统(AMDIS)联用,快速鉴定出48种挥发性成分,包括4种苯乙酮、3种脂肪酸酯、13种苯丙素类化合物和19种倍半萜类化合物。其中大部分成分来自桂枝。桂枝挥发油已被证明具有多种药理活性。这有助于理解GFC的药理机制。此外,AMDIS在分析复杂中药制剂方面被证明是高效且可靠的。快速分离液相色谱(RRLC)与电喷雾电离四极杆飞行时间串联质谱(ESI-Q-TOF MS/MS)联用,鉴定出70种非挥发性成分,包括6种苯乙酮、12种没食子酰葡萄糖、31种单萜糖苷、3种酚类化合物和12种三萜酸。首次通过TOF MS/MS研究了已鉴定成分的裂解行为,尤其是低分辨率质谱难以鉴定的三萜酸。总结了已鉴定三萜酸的特征离子和典型裂解规律。GC-MS-AMDIS和RRLC-ESI-Q-TOF MS/MS的联合应用对GFC以及其他中药产品的整体定性分析有很大帮助。